BioTech Medics, Inc.
BMCS · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $7 | $2 | $14 |
| - Cash | $0 | $0 | $0 | -$0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $7 | $2 | $14 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | 0 | -0.001 | -0.002 |
| % Growth | – | 100% | 62.5% | – |
| Operating Cash Flow | – | -$0 | -$0 | -$0 |
| Capital Expenditures | – | $0 | $0 | -$0 |
| Free Cash Flow | – | -$0 | -$0 | -$0 |